Quality of life and complementary and alternative medicine use among cancer patients in Turkey

dc.authoridCan, Gulbeyaz/0000-0002-5368-0893
dc.authorwosidAydiner, Adnan/AAU-4591-2020
dc.authorwosidCan, Gulbeyaz/Q-2079-2015
dc.contributor.authorCan, Gulbeyaz
dc.contributor.authorErol, Ozgul
dc.contributor.authorAydiner, Adnan
dc.contributor.authorTopuz, Erkan
dc.date.accessioned2024-06-12T11:13:11Z
dc.date.available2024-06-12T11:13:11Z
dc.date.issued2009
dc.departmentTrakya Üniversitesien_US
dc.description.abstractAim: The purpose of this study was to assess the relationships between quality of life and use of complementary and alternative medicine (CAM) among Turkish cancer patients. Methods: This cross-sectional study was conducted in Istanbul University Institute of Oncology, Turkey. Two-hundred patients were invited and informed consent was obtained, however 179 cancer patients completed the study. The Patient Characteristics form, The Nightingale Symptom Assessment Scale and The Functional Assessment of Cancer Therapy Scale were used in the evaluation of the patients' characteristics and quality of life. Results: Some form of CAM had been used by 71.5% of the sample. Frequently used CAM methods appeared to be religious practices (68.2%) and only 37.4% of the patients used herbs. However, female patients, single patients, and individuals with metastatic disease and worse quality of life showed a tendency to use CAM more often. More than one-third of our patients began to use CAM immediately after being diagnosed with cancer and factors associated with CAM use varied according to the type of CAM. Although CAM use did not affect the patients' quality of life, logistic regression analysis revealed that gender, type of cancer diagnosis and education level were important factors to be considered in different CAM therapies. Conclusion: CAM use is common in cancer patients in Turkey. More discussion about CAM use should take place between patients and health professionals to inform the patients' decisions. (C) 2009 Elsevier Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/j.ejon.2009.03.007
dc.identifier.endpage294en_US
dc.identifier.issn1462-3889
dc.identifier.issn1532-2122
dc.identifier.issue4en_US
dc.identifier.pmid19395312en_US
dc.identifier.scopus2-s2.0-69249220434en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage287en_US
dc.identifier.urihttps://doi.org/10.1016/j.ejon.2009.03.007
dc.identifier.urihttps://hdl.handle.net/20.500.14551/23462
dc.identifier.volume13en_US
dc.identifier.wosWOS:000270122700009en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofEuropean Journal Of Oncology Nursingen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectQuality Of Lifeen_US
dc.subjectComplementary And Alternative Medicineen_US
dc.subjectChemotherapyen_US
dc.subjectCanceren_US
dc.subjectTherapiesen_US
dc.subjectPrevalenceen_US
dc.subjectBreasten_US
dc.subjectSupplementsen_US
dc.subjectMotivesen_US
dc.titleQuality of life and complementary and alternative medicine use among cancer patients in Turkeyen_US
dc.typeArticleen_US

Dosyalar